July 01, 2025 By Joan Tupponce With the popularity of weight loss and obesity medications soaring, its important to know all the ins and outs of glucagon-like peptide-1 (GLP-1) receptor agonists
If you notice a consistent downward trend in your weight, it may indicate that semaglutide GLP-1 is effectively supporting your weight loss goals
Once-Weekly Semaglutide in Adults with Overweight or Obesity
We want to support you long term, and there are plenty of ways to do that. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more
Retrieved August 21, 2025, from Bozick, R., Donofry, S
In this blog post we examine the overall market context from the top-selling drugs of 2025 H1 to the surge of dealmaking in obesity therapeutics and then drill into why Eli Lilly, with its GLP-1 pipeline and commercialization strategy, has emerged as the biggest beneficiary of this trend